DK0508307T3 - Optisk aktive sekundære aminforbindelser, fremgangsmåde til fremstilling af en optisk aktiv sekundær aminforbindelse og fremgangsmåde til fremstilling af en optisk aktiv carboxylsyre ved anvendelse af denne forbindelse - Google Patents

Optisk aktive sekundære aminforbindelser, fremgangsmåde til fremstilling af en optisk aktiv sekundær aminforbindelse og fremgangsmåde til fremstilling af en optisk aktiv carboxylsyre ved anvendelse af denne forbindelse

Info

Publication number
DK0508307T3
DK0508307T3 DK92105682.6T DK92105682T DK0508307T3 DK 0508307 T3 DK0508307 T3 DK 0508307T3 DK 92105682 T DK92105682 T DK 92105682T DK 0508307 T3 DK0508307 T3 DK 0508307T3
Authority
DK
Denmark
Prior art keywords
optically active
secondary amine
compound
active secondary
preparing
Prior art date
Application number
DK92105682.6T
Other languages
Danish (da)
English (en)
Inventor
Yukio Yoneyoshi
Junko Kudo
Toshio Nishioka
Original Assignee
Sumitomo Chemical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sumitomo Chemical Co filed Critical Sumitomo Chemical Co
Application granted granted Critical
Publication of DK0508307T3 publication Critical patent/DK0508307T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/56—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms
    • C07C217/58—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms with amino groups and the six-membered aromatic ring, or the condensed ring system containing that ring, bound to the same carbon atom of the carbon chain
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/02—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C215/04—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated
    • C07C215/06—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and acyclic
    • C07C215/16—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and acyclic the nitrogen atom of the amino group being further bound to carbon atoms of six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B57/00—Separation of optically-active compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/46—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C215/48—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by hydroxy groups
    • C07C215/50—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by hydroxy groups with amino groups and the six-membered aromatic ring, or the condensed ring system containing that ring, bound to the same carbon atom of the carbon chain
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C251/02—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton containing imino groups
    • C07C251/24—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton containing imino groups having carbon atoms of imino groups bound to carbon atoms of six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK92105682.6T 1991-04-08 1992-04-02 Optisk aktive sekundære aminforbindelser, fremgangsmåde til fremstilling af en optisk aktiv sekundær aminforbindelse og fremgangsmåde til fremstilling af en optisk aktiv carboxylsyre ved anvendelse af denne forbindelse DK0508307T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP7509691 1991-04-08
JP31249091 1991-11-27

Publications (1)

Publication Number Publication Date
DK0508307T3 true DK0508307T3 (da) 1995-12-27

Family

ID=26416239

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92105682.6T DK0508307T3 (da) 1991-04-08 1992-04-02 Optisk aktive sekundære aminforbindelser, fremgangsmåde til fremstilling af en optisk aktiv sekundær aminforbindelse og fremgangsmåde til fremstilling af en optisk aktiv carboxylsyre ved anvendelse af denne forbindelse

Country Status (8)

Country Link
US (2) US5298660A (ko)
EP (1) EP0508307B1 (ko)
JP (1) JP3031048B2 (ko)
KR (1) KR100220266B1 (ko)
CA (1) CA2065476C (ko)
DE (1) DE69206306T2 (ko)
DK (1) DK0508307T3 (ko)
HU (1) HU214741B (ko)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6001884A (en) * 1991-08-23 1999-12-14 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
CA2173747C (en) * 1991-08-23 2006-05-23 Edward F. Nemeth Calcium receptor-active arylalkyl amines
US5763569A (en) * 1991-08-23 1998-06-09 The Brigham And Women's Hospital, Inc Calcium receptor-active molecules
US6313146B1 (en) 1991-08-23 2001-11-06 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US6011068A (en) * 1991-08-23 2000-01-04 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US5858684A (en) * 1991-08-23 1999-01-12 The Brigham And Women's Hospital, Inc. Method of screening calcium receptor-active molecules
US6031003A (en) * 1991-08-23 2000-02-29 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US5688938A (en) * 1991-08-23 1997-11-18 The Brigham & Women's Hospital, Inc. Calcium receptor-active molecules
US5962314A (en) * 1993-02-23 1999-10-05 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
EP1275635A1 (en) 1994-10-21 2003-01-15 Nps Pharmaceuticals, Inc. Calcium receptor-active compounds
CA2172946C (en) * 1995-03-30 2008-01-22 Koji Hagiya N-(.alpha.-alkylbenzylidene)-.alpha.-phenylalkylamine, its use and process for producing the same and process for producing intermediate
US5677469A (en) * 1995-05-18 1997-10-14 Sepracor, Inc. Process for resolving chiral acids with 1-aminoindan-2-ols
ES2326004T3 (es) 1996-05-01 2009-09-28 Nps Pharmaceuticals, Inc. Compuestos activos de receptor de ion inorganico.
US6268525B1 (en) 1998-01-29 2001-07-31 Sumitomo Chemical Company, Limited Process for producing optically active chrysanthemic acid
JP4576642B2 (ja) * 1998-01-29 2010-11-10 住友化学株式会社 光学活性な菊酸の製造方法
AU6873700A (en) * 1999-09-08 2001-04-10 Daiichi Pharmaceutical Co., Ltd. Process for the preparation of benzoxazine derivatives and intermediates therefor
AU2001257022B2 (en) * 2000-04-13 2005-02-03 Mayo Foundation For Medical Education And Research Abeta 42 lowering agents
AU2003303655A1 (en) * 2003-01-03 2004-07-29 Council Of Scientific And Industrial Research Process for preparing (+)-2-(4-chlorophenyl)-3-methyl butanoic acid
EP1603548A4 (en) * 2003-02-05 2007-10-10 Myriad Genetics Inc COMPOSITION AND METHOD FOR TREATING NEURODEGENERATIVE DISORDERS
CA2532207A1 (en) * 2003-07-11 2005-07-21 Myriad Genetics, Inc. Pharmaceutical methods, dosing regimes and dosage forms for the treatment of alzheimer's disease
WO2006001877A2 (en) * 2004-04-13 2006-01-05 Myriad Genetics, Inc. Combination treatment for neurodegenerative disorders comprising r-flurbiprofen
AU2005241023A1 (en) * 2004-04-29 2005-11-17 Keystone Retaining Wall Systems, Inc. Veneers for walls, retaining walls and the like
BRPI0514303A (pt) * 2004-08-11 2008-06-10 Myriad Genetics Inc composição farmacêutica e método para tratar distúrbios neurodegenerativos
WO2006020850A2 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
WO2006020852A2 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
US20070042034A1 (en) * 2005-07-22 2007-02-22 Myriad Genetics, Incorporated High drug load formulations and dosage forms
US8399615B2 (en) * 2005-08-19 2013-03-19 Vertex Pharmaceuticals Incorporated Processes and intermediates
US20080033045A1 (en) * 2006-07-07 2008-02-07 Myriad Genetics, Incorporated Treatment of psychiatric disorders
WO2008095186A1 (en) * 2007-02-01 2008-08-07 Myriad Genetics, Inc. Drug substance preparations, pharmaceutical compositions and dosage forms
JP5176452B2 (ja) * 2007-09-27 2013-04-03 住友化学株式会社 光学活性なテトラヒドロピラニルグリシン化合物の製造方法
WO2010010359A2 (en) * 2008-07-24 2010-01-28 Cilpa Limited A process for the preparation of cinacalcet and its salts
GB201216893D0 (en) 2012-09-21 2012-11-07 Aesica Pharmaceuticals Ltd Drug substance preparations, pharmaceutical compositions and dosage forms comprising s-(+)-flurbiprofen

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4834736B1 (ko) * 1969-05-14 1973-10-23
US3739019A (en) * 1969-07-02 1973-06-12 Sumitomo Chemical Co Preparation of optically active trans chrysanthemic acid
JPS5123497B2 (ko) * 1972-01-07 1976-07-17
JPS49109344A (ko) * 1973-02-27 1974-10-17
DE2826952A1 (de) * 1978-06-20 1980-01-10 Bayer Ag Enantiomerentrennung von chiralen carbonsaeuren
JPS5910724B2 (ja) * 1979-08-24 1984-03-10 旭化成株式会社 エチレンの連続重合法
US4259521A (en) * 1979-10-09 1981-03-31 American Cyanamid Company Process for resolving DL-mandelic acid
US4536601A (en) * 1982-09-28 1985-08-20 Dainippon Pharmaceutical Co., Ltd. Optically active N-substituted phenylalaninols and use thereof
JPH0667871B2 (ja) * 1986-07-31 1994-08-31 住友化学工業株式会社 第一菊酸の光学分割法
US5011996A (en) * 1988-07-20 1991-04-30 Bayer Aktiengesellschaft Process for the preparation of amines
CA2023954C (en) * 1989-10-17 1999-05-04 Hiroyuki Nohira Process for the optical resolution of 2-(3-benzoyl) phenylpropionic acid

Also Published As

Publication number Publication date
HUT60995A (en) 1992-11-30
CA2065476A1 (en) 1992-10-09
JP3031048B2 (ja) 2000-04-10
JPH05201938A (ja) 1993-08-10
HU214741B (hu) 1998-10-28
KR100220266B1 (ko) 1999-10-01
EP0508307B1 (en) 1995-11-29
EP0508307A2 (en) 1992-10-14
KR920019721A (ko) 1992-11-19
CA2065476C (en) 2003-10-14
US5298660A (en) 1994-03-29
US5510519A (en) 1996-04-23
DE69206306T2 (de) 1996-06-13
EP0508307A3 (en) 1993-02-03
DE69206306D1 (de) 1996-01-11
HU9201186D0 (en) 1992-07-28

Similar Documents

Publication Publication Date Title
DK0508307T3 (da) Optisk aktive sekundære aminforbindelser, fremgangsmåde til fremstilling af en optisk aktiv sekundær aminforbindelse og fremgangsmåde til fremstilling af en optisk aktiv carboxylsyre ved anvendelse af denne forbindelse
DK68595A (da) Fremgangsmåde til fremstilling af clavulansyre
DK0566468T3 (da) Fremgangsmåde til fremstilling af et biphenylderivat
DK0506973T3 (da) Fremgangsmåde til fremstilling af et aminocarboxylsyresalt
NO891650D0 (no) Fremgangsmaate ved fremstilling av pyridonkarboksylsyrederivater.
FI903104A0 (fi) Analogiamenetelmä asetyylikoliiniesteraasi-inhibiittoreina käyttökelpoisten yhdisteiden valmistamiseksi
DK157009C (da) Fremgangsmaade til fremstilling af 1-(3-mercapto-2s-methylpropionyl)-pyrrolidin-2s-carboxylsyre
PT99242A (pt) Processo para a preparacao de agentes insecticidas e acaricidas de bis- e tris(trifluorometil)arilpirrole
DK0741732T3 (da) Fremgangsmåde til dannelse af et clavulansyresalt
PT88364A (pt) Process for preparing novel hmg-coa reductase inhibitors
DK412488A (da) Fremgangsmaade til fremstilling af guinoloncarboxylsyrer
DK0607795T3 (da) Fremgangsmåde til fremstilling af 2-alkyl-4-fluormethylthiazolcarboxylsyrealkylestere
DK247181A (da) Fremgangsmaade til fremstilling af n-(cykloalkyl)- aminosyreforbindelser
DK39789D0 (da) Fremgangsmaade til fremstilling af n-phosphonmethyliminodieddikesyre
DE69410222T2 (de) Verfahren zur Herstellung von optisch aktiven Erythro-3-amino-1,2-epoxy-Verbindungen
DK0519512T3 (da) Mikrobiologisk fremgangsmåde til fremstilling af 5-hydroxypyrazincarboxylsyre
DK0614908T3 (da) Fremgangsmåde til fremstilling af 3beta-aminocholansyrederivater.
DK54982A (da) Fremgangsmaade til fremstilling af 4-(1-imidazolylmethyl)-kanelsyre-hydrochlorid-monohydrat
DK148096C (da) Fremgangsmaade til fremstilling af (2-aminothiazol-4-yl)-eddikesyre-hydrochlorid
DK358288D0 (da) Fremgangsmaade til fremstilling af 2-arylthiobenzoesyrer
DK357388D0 (da) Fremgangsmaade til fremstilling af et piperidinylcyklopentylheptensyrederivat
DK0625403T3 (da) Fremgangsmåde til fremstilling af en aktiv slagloddepasta
DK0450491T3 (da) Fremgangsmåde til fremstilling af d-isocitronsyre ved fermentation
DK158462C (da) Fremgangsmaade til fremstilling af 3-alkoxy- eller 3,3-dialkoxycarboxylsyreestere
DK0599036T3 (da) Fremgangsmåde til fremstilling af 2-aryl-5-trifluormethyl-pyrrolforbindelser